24/7 Wall Street
26 Jul 2026, 16:13 UTC · 8w ago
Verdict
Headline takes no side. We score CLS +0.90 across five claims — strongly bullish.
+0.90strongly bullish
More positive than 94% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Celestica has raised its FY2026 revenue guidance to $19 billion and adjusted EPS to $10.15.
More positive than 92% of claims this week
Recent sharp price declines in AI-linked names Applied Digital (APLD) and Navitas Semiconductor (NVTS) raise concerns that $700 billion in annual hyperscaler capex expectations may have outrun actual results.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More negative than 91% of claims this week
Baker Hughes reports a $33.10 billion backlog and $1.4 billion in Power Systems orders specifically tied to data center demand.
So whatProvides concrete evidence that AI infrastructure is driving real-world energy capex and industrial orders.
More positive than 77% of claims this week
Corporate profits are currently growing at a 12.8% year-over-year rate and Q1 2026 GDP accelerated to 2.1%.
More positive than 63% of claims this week
AstraZeneca faces pressure from China's Volume-Based Procurement (VBP) on Farxiga and is awaiting 20+ Phase III readouts this year.
More negative than 71% of claims this week
Which stocks this story touches
More positive than 94% of ticker scores this week
Significant revenue growth, raised FY2026 guidance, and shares up 98% over one year.
More positive than 85% of ticker scores this week
Strong record orders, consecutive EPS beats, and a growing pipeline tied to data center demand.
More negative than 74% of ticker scores this week
Despite strong operational growth, shares crashed nearly 34% in the past month.
More negative than 72% of ticker scores this week
Shares dropped over 43% in the past month and Q1 revenue declined significantly.
More negative than 69% of ticker scores this week
Stock is down year-to-date and the company is facing China VBP pressure on Farxiga.
More positive than 45% of ticker scores this week
Mentioned positively in the context of a successful analyst call, though not the focus of current news.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+19.0%
Price agrees with the score
$363.20 vs $305.28 close before publication (Jul 24) · not market-adjusted
CLS chart →
